Organigram Global Inc. (OGI)
NASDAQ: OGI
· Real-Time Price · USD
1.33
0.09 (7.26%)
At close: May 16, 2025, 3:59 PM
1.35
1.12%
After-hours: May 16, 2025, 07:42 PM EDT
Organigram Global Revenue Breakdown
| Period Ending | Sep 30, 2024 | Aug 31, 2022 | Aug 31, 2021 | Aug 31, 2020 |
|---|---|---|---|---|
| Direct To Patient Medical Revenue Revenue | 1.73M | 7.87M | 8.7M | 10.75M |
| Direct To Patient Medical Revenue Revenue Growth | -78.00% | -9.53% | -19.05% | n/a |
| International Business To Business Revenue | 9.65M | 15.14M | 386K | 3.27M |
| International Business To Business Revenue Growth | -36.25% | +3821.76% | -88.20% | n/a |
| Other Revenue Revenue | 97K | 115K | 202K | 245K |
| Other Revenue Revenue Growth | -15.65% | -43.07% | -17.55% | n/a |
| Wholesale To Licensed Producers Revenue Revenue | 5.31M | 1.3M | 2.06M | 15.18M |
| Wholesale To Licensed Producers Revenue Revenue Growth | +309.09% | -36.99% | -86.43% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.19M | 14.3M | 15.63M | 20.86M | 17.34M | 22.61M | 18.78M | 15.85M | 16.05M | 16.62M | 16.68M | 13.4M | 12.5M | 12.49M | 12.84M | 10.77M | 10.42M | 10.83M | 10.77M | 14.45M | 10.55M | 15.6M | 10.71M | 9.59M | 5.42M | 4.16M | 4.38M | 4.12M | 2.91M | 2.81M | 1.58M | 1.8M | 1.48M | 1.31M | 1.09M | 908.37K | 765.19K | 612.08K | 493.97K | 731.47K |
| Selling, General, and Administrative Revenue Growth | +20.17% | -8.50% | -25.07% | +20.28% | -23.28% | +20.37% | +18.48% | -1.24% | -3.45% | -0.35% | +24.46% | +7.21% | +0.06% | -2.67% | +19.22% | +3.31% | -3.76% | +0.54% | -25.44% | +36.90% | -32.35% | +45.58% | +11.70% | +77.03% | +30.33% | -5.03% | +6.18% | +41.51% | +3.66% | +77.34% | -12.02% | +21.57% | +13.55% | +19.73% | +19.99% | +18.71% | +25.01% | +23.91% | -32.47% | n/a |
| Research and Development Revenue | 2.37M | 1.67M | 2.46M | 2.61M | 4.47M | 4.01M | 3.46M | 3.35M | 2.38M | 2.39M | 1.37M | 1.18M | 1.01M | 1.15M | 890K | 786K | 627K | 371K | 173K | 478K | 247K | 196K | 182K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | +42.11% | -32.24% | -5.60% | -41.66% | +11.48% | +15.71% | +3.43% | +40.50% | -0.29% | +74.07% | +15.96% | +16.65% | -11.51% | +28.88% | +13.23% | +25.36% | +69.00% | +114.45% | -63.81% | +93.52% | +26.02% | +7.69% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 5.8M | 4.76M | 5.1M | 5.4M | 4.59M | n/a | 4.55M | 4.33M | 4.49M | 4.11M | 4.67M | 3.42M | 4.66M | 4.89M | 4.11M | 3.14M | 3.67M | 3.22M | 4.3M | 5.48M | 3.53M | 4.72M | 4.44M | 3.14M | 2.36M | 2.27M | 1.75M | 1.15M | 1.13M | 783.7K | 690.75K | 704.57K | 667.92K | 559.62K | 460.79K | 412.01K | 325.39K | 251.75K | 151.95K | 152.21K |
| Sales and Marketing Revenue Growth | +22.04% | -6.69% | -5.66% | +17.58% | n/a | -100.00% | +4.98% | -3.50% | +9.24% | -12.01% | +36.73% | -26.67% | -4.66% | +19.05% | +30.72% | -14.46% | +14.11% | -25.15% | -21.57% | +55.27% | -25.21% | +6.28% | +41.52% | +33.14% | +3.83% | +29.42% | +52.96% | +1.22% | +44.55% | +13.46% | -1.96% | +5.49% | +19.35% | +21.45% | +11.84% | +26.62% | +29.25% | +65.68% | -0.17% | n/a |